The relative anti-BACH1 autoantibody intensity was significantly higher in patients with ESCC than in healthy controls, especially with early-stage ESCC, than in healthy controls (Fig. 2B). The gene discussed is BACH1; the disease is esophageal squamous cell carcinoma.